{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:38:33Z","timestamp":1780576713947,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100005366","name":"Universitetet i Oslo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12883-017-0851-0","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T05:57:10Z","timestamp":1491371830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis \u2013 a randomized controlled trial"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2529-5664","authenticated-orcid":false,"given":"Trygve","family":"Holm\u00f8y","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas Christoffer","family":"Lindstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik Fink","family":"Eriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linn Hofs\u00f8y","family":"Steffensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margitta T.","family":"Kampman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,4]]},"reference":[{"key":"851_CR1","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","volume":"296","author":"KL Munger","year":"2006","unstructured":"Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296:2832\u20138.","journal-title":"JAMA"},{"key":"851_CR2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1212\/WNL.0b013e31825fdf01","volume":"79","author":"KI L\u00f8ken-Amsrud","year":"2012","unstructured":"L\u00f8ken-Amsrud KI, Holm\u00f8y T, Bakke SJ, Beiske AG, Bjerve KS, Bj\u00f8rnar\u00e5 BT, et al. Vitamin D and disease activity in multiple sclerosis before and during interferon beta treatment. Neurology. 2012;79:267\u201373.","journal-title":"Neurology"},{"key":"851_CR3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.22043","volume":"68","author":"S Simpson Jr","year":"2010","unstructured":"Simpson Jr S, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H, et al. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol. 2010;68:193\u2013203.","journal-title":"Ann Neurol"},{"key":"851_CR4","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3109\/00207454.2014.988332","volume":"125","author":"Z Huang","year":"2015","unstructured":"Huang Z, Qi Y, Du S, Chen G, Yan W. Bone mineral density levels in adults with multiple sclerosis: A meta-analysis. Int J Neurosci. 2015;125:904\u201312.","journal-title":"Int J Neurosci"},{"key":"851_CR5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s40263-014-0173-3","volume":"28","author":"S Gupta","year":"2014","unstructured":"Gupta S, Ahsan I, Mahfooz N, Abdelhamid N, Ramanathan M, Weinstock-Guttman B. Osteoporosis and multiple sclerosis: risk factors, pathophysiology, and therapeutic interventions. CNS Drugs. 2014;28:731\u201342.","journal-title":"CNS Drugs"},{"key":"851_CR6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00415-009-5337-6","volume":"257","author":"LH Steffensen","year":"2010","unstructured":"Steffensen LH, Mellgren SI, Kampman MT. Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis. J Neurol. 2010;257:410\u20138.","journal-title":"J Neurol"},{"key":"851_CR7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1212\/WNL.0b013e3182242d34","volume":"77","author":"SM Moen","year":"2011","unstructured":"Moen SM, Celius EG, Sandvik L, Nordsletten L, Eriksen EF, Holmoy T. Low bone mass in newly diagnosed multiple sclerosis and clinically isolated syndrome. Neurology. 2011;77:151\u20137.","journal-title":"Neurology"},{"key":"851_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsams.2016.08.004","author":"LN Silk","year":"2016","unstructured":"Silk LN, Greene DA, Baker MK, Jander CB. The effect of calcium and vitamin D supplementation on bone health of male Jockeys. J Sci Med Sport. 2016; doi: 10.1016\/j.jsams.2016.08.004 .","journal-title":"J Sci Med Sport"},{"key":"851_CR9","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/jbmr.418","volume":"26","author":"MT Bazelier","year":"2011","unstructured":"Bazelier MT, van Staa TP, Uitdehaag BM, Cooper C, Leufkens HG, Vestergaard P, et al. The risk of fracture in patients with multiple sclerosis: the UK general practice research database. J Bone Miner Res. 2011;26:2271\u20139.","journal-title":"J Bone Miner Res"},{"key":"851_CR10","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1177\/1352458511426739","volume":"18","author":"MT Bazelier","year":"2012","unstructured":"Bazelier MT, de Vries F, Bentzen J, Vestergaard P, Leufkens HG, van Staa TP, et al. Incidence of fractures in patients with multiple sclerosis: the Danish National Health Registers. Mult Scler. 2012;18:622\u20137.","journal-title":"Mult Scler"},{"key":"851_CR11","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1212\/WNL.0b013e318259e0ff","volume":"78","author":"MT Bazelier","year":"2012","unstructured":"Bazelier MT, van Staa TP, Uitdehaag BM, Cooper C, Leufkens HG, Vestergaard P, et al. Risk of fractures in patients with multiple sclerosis: a population-based cohort study. Neurology. 2012;78:1967\u201373.","journal-title":"Neurology"},{"key":"851_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2377-12-135","volume":"12","author":"SV Ramagopalan","year":"2012","unstructured":"Ramagopalan SV, Seminog O, Goldacre R, Goldacre MJ. Risk of fractures in patients with multiple sclerosis: record-linkage study. BMC Neurol. 2012;12:135. doi: 10.1186\/1471-2377-12-135 .","journal-title":"BMC Neurol"},{"key":"851_CR13","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1177\/1352458513489756","volume":"19","author":"E James","year":"2013","unstructured":"James E, Dobson R, Kuhle J, Baker D, Giovannoni G, Ramagopalan SV. The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis. Mult Scler. 2013;19:1571\u20139.","journal-title":"Mult Scler"},{"key":"851_CR14","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1177\/1352458510368985","volume":"16","author":"AP Hearn","year":"2010","unstructured":"Hearn AP, Silber E. Osteoporosis in multiple sclerosis. Mult Scler. 2010;16:1031\u201343.","journal-title":"Mult Scler"},{"key":"851_CR15","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1177\/1352458512453362","volume":"18","author":"R Dobson","year":"2012","unstructured":"Dobson R, Ramagopalan S, Giovannoni G. Bone health and multiple sclerosis. Mult Scler. 2012;18:1522\u20138.","journal-title":"Mult Scler"},{"key":"851_CR16","doi-asserted-by":"crossref","unstructured":"Kampman MT, Eriksen EF, Holmoy T. Multiple sclerosis, a cause of secondary osteoporosis? What is the evidence and what are the clinical implications? Acta Neurol Scand Suppl. 2011:44\u20139.","DOI":"10.1111\/j.1600-0404.2011.01543.x"},{"key":"851_CR17","volume-title":"Institute of Medicine. Daily reference values for calcium and vitamin D","author":"TCL RossCA","year":"2011","unstructured":"RossCA TCL, Yaktine AL, Del Valle HB. Institute of Medicine. Daily reference values for calcium and vitamin D. Washington DC: The National Academic Press; 2011."},{"key":"851_CR18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1359\/jbmr.090728","volume":"25","author":"M Priemel","year":"2010","unstructured":"Priemel M, von DC, Klatte TO, Kessler S, Schlie J, Meier S, et al. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res. 2010;25:305\u201312.","journal-title":"J Bone Miner Res"},{"key":"851_CR19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.beem.2011.06.009","volume":"25","author":"R Vieth","year":"2011","unstructured":"Vieth R. Why the minimum desirable serum 25-hydroxyvitamin D level should be 75 nmol\/L (30 ng\/ml). Best Pract Res Clin Endocrinol Metab. 2011;25:681\u201391.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"851_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2017.01.021","author":"P Pludowski","year":"2017","unstructured":"Pludowski P, Holick MF, Grant WB, Konstantynowicz J, Mascarenhas MR, Haq A, et al. Vitamin D supplementation guidelines. J Steroid Biochem Mol Biol. 2017; doi: 10.1016\/j.jsbmb.2017.01.021 .","journal-title":"J Steroid Biochem Mol Biol"},{"key":"851_CR21","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/s00415-011-5980-6","volume":"258","author":"LH Steffensen","year":"2011","unstructured":"Steffensen LH, Jorgensen L, Straume B, Mellgren SI, Kampman MT. Can vitamin D(3) supplementation prevent bone loss in persons with MS? A placebo-controlled trial. J Neurol. 2011;258:1624\u201331.","journal-title":"J Neurol"},{"key":"851_CR22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1055\/s-0033-1345139","volume":"45","author":"R Jorde","year":"2013","unstructured":"Jorde R, Grimnes G, Hutchinson MS, Kjaergaard M, Kamycheva E, Svartberg J. Supplementation with vitamin D does not increase serum testosterone levels in healthy males. Horm Metab Res. 2013;45:675\u201381.","journal-title":"Horm Metab Res"},{"key":"851_CR23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/1352458515600248","volume":"22","author":"P Bhargava","year":"2016","unstructured":"Bhargava P, Steele SU, Waubant E, Revirajan NR, Marcus J, Dembele M, et al. Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls. Mult Scler. 2016;22:753\u201360.","journal-title":"Mult Scler"},{"key":"851_CR24","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00223-014-9842-y","volume":"94","author":"H Johansson","year":"2014","unstructured":"Johansson H, Oden A, Kanis JA, McCloskey EV, Morris HA, Cooper C, et al. A meta-analysis of reference markers of bone turnover for prediction of fracture. Calcif Tissue Int. 2014;94:560\u20137.","journal-title":"Calcif Tissue Int"},{"key":"851_CR25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","volume":"22","author":"S Vasikaran","year":"2011","unstructured":"Vasikaran S, Eastell R, Bruyere O, Foldes AJ, Garnero P, Griesmacher A, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int. 2011;22:391\u2013420.","journal-title":"Osteoporos Int"},{"key":"851_CR26","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1177\/1352458511434607","volume":"18","author":"MT Kampman","year":"2012","unstructured":"Kampman MT, Steffensen LH, Mellgren SI, Jorgensen L. Effect of vitamin D3 supplementation on relapses, disease progression and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial. Mult Scler. 2012;18:1144\u201351.","journal-title":"Mult Scler"},{"key":"851_CR27","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1017\/S1368980007702872","volume":"10","author":"A Hjartaker","year":"2007","unstructured":"Hjartaker A, Andersen LF, Lund E. Comparison of diet measures from a food-frequency questionnaire with measures from repeated 24-hour dietary recalls. The Norwegian Women and Cancer Study. Public Health Nutr. 2007;10:1094\u2013103.","journal-title":"Public Health Nutr"},{"key":"851_CR28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/1352458516654310","volume":"23","author":"E Rosjo","year":"2017","unstructured":"Rosjo E, Lossius A, Abdelmagid N, Lindstrom JC, Kampman MT, Jorgensen L, et al. Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis. Mult Scler Mult Scler. 2017;23:395\u2013402.","journal-title":"Mult Scler Mult Scler"},{"key":"851_CR29","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1210\/jc.2009-1294","volume":"95","author":"J Aloia","year":"2010","unstructured":"Aloia J, Bojadzievski T, Yusupov E, Shahzad G, Pollack S, Mikhail M, et al. The relative influence of calcium intake and vitamin D status on serum parathyroid hormone and bone turnover biomarkers in a double-blind, placebo-controlled parallel group, longitudinal factorial design. J Clin Endocrinol Metab. 2010;95:3216\u201324.","journal-title":"J Clin Endocrinol Metab"},{"key":"851_CR30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11845-012-0818-5","volume":"182","author":"MJ McKenna","year":"2013","unstructured":"McKenna MJ, Murray B, Lonergan R, Redmond JM. Immunomodulators for multiple sclerosis may ameliorate spinal bone loss. Ir J Med Sci. 2013;182:29\u201332.","journal-title":"Ir J Med Sci"},{"key":"851_CR31","doi-asserted-by":"crossref","first-page":"175762","DOI":"10.1016\/j.bcp.2009.01.007","volume":"77","author":"AK Abraham","year":"2009","unstructured":"Abraham AK, Ramanathan M, Weinstock-Guttman B, Mager DE. Mechanisms of interferon-beta effects on bone homeostasis. Biochem Pharmacol. 2009;77:175762.","journal-title":"Biochem Pharmacol"},{"key":"851_CR32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11845-009-0275-y","volume":"178","author":"MT Kampman","year":"2009","unstructured":"Kampman MT, Steffensen LH. Comment on Shuhaibar et al: Favourable effect of immunomodulator therapy on bone mineral density in multiple sclerosis. Ir J Med Sci. 2009;178:235\u20136.","journal-title":"Ir J Med Sci"},{"key":"851_CR33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000339360","volume":"39","author":"J Saltyte Benth","year":"2012","unstructured":"Saltyte Benth J, Myhr KM, Loken-Amsrud KI, Beiske AG, Bjerve KS, Hovdal H, et al. Modelling and prediction of 25-hydroxyvitamin D levels in Norwegian relapsing-remitting multiple sclerosis patients. Neuroepidemiology. 2012;39:84\u201393.","journal-title":"Neuroepidemiology"},{"key":"851_CR34","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3109\/00207454.2014.988332","volume":"125","author":"Z Huang","year":"2015","unstructured":"Huang Z, Qi Y, Du S, Chen G, Yan W. BMI levels with MS Bone mineral density levels in adults with multiple sclerosis: a meta-analysis. Int J Neurosci. 2015;125:904\u201312.","journal-title":"Int J Neurosci"},{"key":"851_CR35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa1109617","volume":"367","author":"HA Bischoff-Ferrari","year":"2012","unstructured":"Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med. 2012;367:40\u20139.","journal-title":"N Engl J Med"},{"key":"851_CR36","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.autrev.2010.06.009","volume":"9","author":"JC Souberbielle","year":"2010","unstructured":"Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev. 2010;9:709\u201315.","journal-title":"Autoimmun Rev"},{"key":"851_CR37","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1210\/jc.2013-2653","volume":"98","author":"BW Hollis","year":"2013","unstructured":"Hollis BW, Wagner CL. Clinical review: The role of the parent compound vitamin D with respect to metabolism and function: Why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab. 2013;98:4619\u201328.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-017-0851-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T12:16:20Z","timestamp":1719144980000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-017-0851-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,4]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["851"],"URL":"https:\/\/doi.org\/10.1186\/s12883-017-0851-0","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,4]]},"article-number":"67"}}